GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicinetm, today announced a co-marketing partnership aimed at advancing precision oncology care.
1don MSN
Aramark officially announced an agreement to run concessions for the Huskers after the Nebraska Board of Regents approved the ...
Companies has signed a definitive agreement with Nabors Energy Transition Corp II to form a combined entity named e2Companies ...
Inc., a company specializing in laboratory analytical instruments, has terminated a material definitive agreement with Cowen and Company, LLC. This termination, effective February 14, 2025, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback